Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Response to treatment in a prospective national infantile spasms cohort
Coryell, Jason , Nickels, Katherine , Ryan, Nicole, Leister, Erin, Loddenkemper, Tobias , Grinspan, Zachary M. , Hartman, Adam L. , Kossoff, Eric H. , Gaillard, William D. , Mytinger, John R. , Joshi, Sucheta M. , Shellhaas, Renée A. , Sullivan, Joseph , Dlugos, Dennis , Hamikawa, Lorie, Berg, Anne T. , Millichap, J Gordon , Knupp, Kelly G. , Nordli, Douglas R. , Wirrell, Elaine , Millichap, John , Shellhaas, Renée A , Gaillard, William D , Loddenkemper, Tobias , Berg, Anne T , Grinspan, Zachary , Nickels, Katherine C , Coryell, Jason

Annals of Neurology | December 24, 2015 | Volume: 79 | Issue: 3 | Pages: 475-484

10.1002/ana.24594 | PMID 26704170 Get It

ObjectiveInfantile spasms are seizures associated with a severe epileptic encephalopathy presenting in the first 2 years of life, and optimal treatment continues to be debated. This study evaluates early and sustained response to initial treatments and addresses both clinical remission and electrographic resolution of hypsarrhythmia. Secondarily, it assesses whether response to treatment differs by etiology or developmental status.MethodsThe National Infantile Spasms Consortium established a multicenter, prospective database enrolling infants with new diagnosis of infantile spasms. Children were considered responders if there was clinical remission and resolution of hypsarrhythmia that was sustained at 3 months after first treatment initiation. Standard treatments of adrenocorticotropic hormone (ACTH), oral corticosteroids, and vigabatrin were considered individually, and all other nonstandard therapies were analyzed collectively. Developmental status and etiology were assessed. We compared response rates by treatment group using chi‐square tests and multivariate logistic regression models.ResultsTwo hundred thirty infants were enrolled from 22 centers. Overall, 46% of children receiving standard therapy responded, compared to only 9% who responded to nonstandard therapy (p < 0.001). Fifty‐five percent of infants receiving ACTH as initial treatment responded, compared to 39% for oral corticosteroids, 36% for vigabatrin, and 9% for other (p < 0.001). Neither etiology nor development significantly modified the response pattern by treatment group.InterpretationResponse rate varies by treatment choice. Standard therapies should be considered as initial treatment for infantile spasms, including those with impaired development or known structural or genetic/metabolic etiology. ACTH appeared to be more effective than other standard therapies. ANN NEUROL 2016;79:475–484
Addressing the Interprofessional Collaboration Competencies of the Association of American Medical Colleges: A Systematic Review of Assessment Instruments in Undergraduate Medical Education
Havyer, Rachel D. , Nelson, Darlene R. , Wingo, Majken T. , Comfere, Nneka I. , Halvorsen, Andrew J. , McDonald, Furman S., Reed, Darcy A.

Academic Medicine | December 24, 2015 | Volume: 91 | Issue: 6 | Pages: 865-888

10.1097/acm.0000000000001053 | PMID 26703415 Get It

Purpose To summarize characteristics and validity evidence of tools that assess teamwork in undergraduate medical education (UME), and provide recommendations for addressing the interprofessional collaboration competencies of the Association of American Medical Colleges (AAMC). Method The authors conducted a systematic review, searching MEDLINE, MEDLINE In-process, CINAHL, and PsycINFO from January 1, 1979, through April 1, 2014; they searched reference lists and national meeting abstracts. They included original research reports that described a quantitative tool used to assess teamwork in UME. They abstracted characteristics and validity evidence for the tools, plus study quality, according to established frameworks. Two authors independently abstracted 25% of articles and calculated agreement. Authors then applied predefined criteria to identify tools best suited to address the AAMC’s teamwork competencies. Results Of 13,549 citations, 70 articles describing 64 teamwork assessment tools were included. Of these 64 tools, 27 (42%) assessed teamwork in classroom, 31 (48%) in simulation, and only 7 (11%) in actual clinical settings. The majority (47; 73%) of tools assessed medical students’ teamwork in interprofessional teams. On the basis of content concordance, strength of validity evidence, generalizability of scores, and level of outcomes, four published tools were recommended to assess the AAMC’s teamwork competencies: the Collaborative Healthcare Interdisciplinary Relationship Planning Scale, Readiness for Interprofessional Learning Scale, Communication and Teamwork Skills assessment, and Teamwork Mini-Clinical Evaluation Exercise. Conclusions Substantial validity evidence supports the use of several UME teamwork assessments. Four tools have been appropriately designed and sufficiently studied to constitute appropriate assessments of the AAMC’s teamwork competencies.
Cytomegalovirus disease is associated with higher all‐cause mortality after lung transplantation despite extended antiviral prophylaxis
Lesnick, Timothy G. , Kremers, Walter K. , Kennedy, Cassie C. , Beam, Elena , Razonable, Raymund R. , Kennedy, Cassie C , Kremers, Walter K

Clinical Transplantation | December 24, 2015 | Volume: 30 | Issue: 3 | Pages: 270-278

10.1111/ctr.12686 | PMID 26701733 Get It

AbstractBackgroundThe duration of anticytomegalovirus (CMV) prophylaxis after lung transplantation (LT) varies among transplant centers.MethodsA retrospective review of CMV donor‐seropositive/recipient‐seronegative (D+/R−) and CMV recipient‐seropositive (R+) LT patients between January 2005 and September 2012 was performed. Starting January 2007, valganciclovir prophylaxis was given for at least 12 months (often lifelong) for CMV D+/R− and extended from three to six months for R+ LT patients. Risks of CMV infection and CMV disease, and mortality after LT, were assessed.ResultsA total of 88 LT patients were studied, including 32 CMV D+/R−, and 56 R+ patients. During the follow‐up period, 11 (12.5%) patients had asymptomatic CMV infection, and nine (10.3%) developed CMV disease. CMV disease (HR, 4.189; 95% CI: 1.672–10.495; p = 0.002) and CMV infection and disease (HR, 3.775; 95% CI: 1.729–8.240; p = 0.001) were significant risk factors for mortality. Overall, no significant difference was observed in rates of CMV infection or disease among LT recipients who received shorter vs. extended CMV prophylaxis.ConclusionsDespite extended prophylaxis, LT patients remain at risk of CMV infection and disease. CMV remains associated with increased mortality after transplantation.
Critically re-evaluating a common technique
Geisbush, Thomas , Jones, Lyell K. , Weiss, Michael , Mozaffar, Tahseen , Gronseth, Gary , Rutkove, Seward B. , Narayanaswami, Pushpa , Jones, Lyell K

Neurology | December 24, 2015 | Volume: 86 | Issue: 3 | Pages: 218-223

10.1212/wnl.0000000000002292 | PMID 26701380 Get It

Measuring the value of neurology
Jones, Lyell K. , Nuwer, Marc R. , Jones, Lyell K

Neurology | December 24, 2015 | Volume: 86 | Issue: 4 | Pages: 320-321

10.1212/wnl.0000000000002290 | PMID 26701377 Get It

UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma
Feldman, Andrew L. , Galardy, Paul J. , Bedekovics, Tibor , Hussain, Sajjad, Feldman, Andrew L

Blood | December 24, 2015 | Volume: 127 | Issue: 12 | Pages: 1564-1574

10.1182/blood-2015-07-656678 | PMID 26702068 Get It

Key Points The neuronal marker UCH-L1 is induced in, and specifically augments the oncogene-induced transformation of, GCB cells. High levels of UCHL1 identify patients with GC DLBCL with an increased risk for poor outcomes.
Pre‐transplant wasting (as measured by muscle index) is a novel prognostic indicator in lung transplantation
Kelm, Diana J. , Bonnes, Sara L. , Jensen, Michael D. , Eiken, Patrick W. , Hathcock, Matthew , Kremers, Walter K. , Kennedy, Cassie C. , Hathcock, Matthew A, Kennedy, Cassie C , Kremers, Walter K

Clinical Transplantation | December 24, 2015 | Volume: 30 | Issue: 3 | Pages: 247-255

10.1111/ctr.12683 | PMID 26701203 Get It

Abstract Background Frailty in non‐transplant populations increases morbidity and mortality. Muscle wasting is an important frailty characteristic. Low body mass index is used to measure wasting, but can over‐ or underestimate muscle mass. Computed tomography ( CT ) software can directly measure muscle mass. It is unknown if muscle wasting is important in lung transplantation. Aim and Methods The aim of this single‐center, retrospective cohort study was to determine whether pre‐transplant low muscle mass (as measured by CT using Slice‐O‐matic software at L2–L3 interspace) was associated with post‐transplantation mortality, hospital and intensive care unit length of stay ( LOS ), duration of mechanical ventilation, or primary graft dysfunction. Lung transplant recipients from 2000 to 2012 with a CT scan less than six months prior to transplant were included. Univariate, multivariate, and Kaplan–Meier analyses were conducted. Results Thirty‐six patients were included. Those with low muscle index (lower 25th percentile) had a worse survival (hazard ratio = 3.83; 95% confidence interval 1.42–10.3; p = 0.007) and longer hospital LOS by an estimated 7.2 d (p = 0.01) when adjusted for age and sex as compared to those with higher muscle index. Conclusion Low muscle index at lung transplantation is associated with worse survival and increased hospital LOS .
Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4‐Year Follow‐Up
Buglioni, Alessia , Cannone, Valentina , Sangaralingham, S. Jeson , Heublein, Denise M., Bailey, Kent R. , Rodeheffer, Richard J. , Sarzani, Riccardo , Burnett, John C. , Sangaralingham, S. Jeson , Scott, Christopher G.

Journal of the American Heart Association | December 24, 2015 | Volume: 4 | Issue: 12 | Pages: No page available

10.1161/jaha.115.002505 | PMID 26702078 Get It

Background We recently reported that normal aldosterone levels are associated with cardiovascular, renal, and metabolic disease in a sample of the US general community (Visit 1). For the current analyses we used the same cohort in a new 4‐year follow‐up study (Visit 2). Methods and Results We measured aldosterone at Visit 1 and analyzed its predictive role for new diseases at Visit 2 (n=1140). We measured aldosterone at Visit 2 and investigated its associations with disease at Visit 2 (n=1368). We analyzed aldosterone continuously and we also dichotomized the variable as whether subjects were in the third tertile versus second and first tertiles. As continuous variable at Visit 1, aldosterone predicted new onset hypertension ( HTN ) ( OR =1.36, CI =1.13–1.63, P =0.001), central obesity ( OR =1.36, CI =1.07–1.73, P =0.011), and use of lipid‐lowering drugs ( OR =1.25, CI =1.05–1.48, P =0.012) at Visit 2, after adjustment for age, sex, and body mass index. When in the third tertile (8.5–88.6 ng/dL), aldosterone predicted type 2 diabetes (T2 DM , OR =1.96, CI =1.03–3.70, P =0.039). At Visit 2, aldosterone remained associated with HTN , obesity, and chronic kidney disease ( CKD ), as reported for Visit 1. However, aldosterone was not associated with heart failure ( HF ) at Visit 1 and 2, nor was aldosterone a predictor of HF between visits. Conclusions Aldosterone predicts new HTN , central obesity, T2 DM , and use of lipid‐lowering drugs in the general community and remains associated with HTN , obesity, and CKD over 4 years. Aldosterone is not associated nor predicts HF . Further studies are warranted to evaluate aldosterone as therapeutic target in the general community.
Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas
Qin, Yuejuan, Cheng, Zi-Ming, Gao, Qing , Silva, Gustavo M. , Prasad, Manju L. , Ocal, Idris Tolgay, Rao, Sarika , Aronin, Neil , Barontini, Marta, Bruder, Jan , Reddick, Robert L., Aguiar, Ricardo C.T. , Ocal, I Tolgay, Toledo, Rodrigo A , Iwata, Shintaro , Chen, Yidong , Dahia, Patricia L. M. , Rao, Sarika N

Clinical Cancer Research | December 23, 2015 | Volume: 22 | Issue: 9 | Pages: 2301-2310

10.1158/1078-0432.ccr-15-1841 | PMID 26700204 Get It

Abstract Purpose: Pheochromocytomas and paragangliomas (PPGL) are genetically heterogeneous tumors of neural crest origin, but the molecular basis of most PPGLs is unknown. Experimental Design: We performed exome or transcriptome sequencing of 43 samples from 41 patients. A validation set of 136 PPGLs was used for amplicon-specific resequencing. In addition, a subset of these tumors was subjected to microarray-based transcription, protein expression, and histone methylation analysis by Western blotting or immunohistochemistry. In vitro analysis of mutants was performed in cell lines. Results: We detected mutations in chromatin-remodeling genes, including histone-methyltransferases, histone-demethylases, and histones in 11 samples from 8 patients (20%). In particular, we characterized a new cancer syndrome involving PPGLs and giant cell tumors of bone (GCT) caused by a postzygotic G34W mutation of the histone 3.3 gene, H3F3A. Furthermore, mutations in kinase genes were detected in samples from 15 patients (37%). Among those, a novel germline kinase domain mutation of MERTK detected in a patient with PPGL and medullary thyroid carcinoma was found to activate signaling downstream of this receptor. Recurrent germline and somatic mutations were also detected in MET, including a familial case and sporadic PPGLs. Importantly, in each of these three genes, mutations were also detected in the validation group. In addition, a somatic oncogenic hotspot FGFR1 mutation was found in a sporadic tumor. Conclusions: This study implicates chromatin-remodeling and kinase variants as frequent genetic events in PPGLs, many of which have no other known germline driver mutation. MERTK, MET, and H3F3A emerge as novel PPGL susceptibility genes. Clin Cancer Res; 22(9); 2301–10. ©2015 AACR.
Mortality Associated With Heart Failure After Myocardial Infarction
Gerber, Yariv , Weston, Susan A., Enriquez‐Sarano, Maurice , Berardi, Cecilia , Chamberlain, Alanna M. , Manemann, Sheila M., Jiang, Ruoxiang , Roger, Véronique L. , Dunlay, Shannon M. , Chamberlain, Alanna M , Enriquez-Sarano, Maurice

Circulation: Heart Failure | December 23, 2015 | Volume: 9 | Issue: 1 | Pages: No page available

10.1161/circheartfailure.115.002460 | PMID 26699392 Get It

Background— Contemporary data are lacking on the prognostic importance of heart failure (HF) after myocardial infarction (MI). We evaluated the prognostic impact of HF post MI according to preserved/reduced ejection fraction and the timing of its occurrence. Methods and Results— All Olmsted County, Minnesota, residents (n=2596) with incident MI diagnosed in 1990 to 2010 and no prior HF were followed through March 2013. Cox models were used to examine (1) the hazard ratios for death associated with HF type and timing and (2) secular trends in survival by HF status. During a mean follow-up of 7.6 years, there were 1116 deaths, 634 in the 902 patients who developed HF (70%) and 482 in the 1694 patients who did not develop HF (28%). After adjustment for age and sex, HF as a time-dependent variable was strongly associated with mortality (hazard ratio =3.31, 95% confidence interval: 2.93–3.75), particularly from cardiovascular causes (hazard ratio =4.20, 95% confidence interval: 3.50–5.03). Further adjustment for MI severity and comorbidity, acute treatment, and recurrent MI moderately attenuated these associations (hazard ratio =2.49 and 2.94 for all-cause and cardiovascular mortality, respectively). Mortality did not differ by ejection fraction, but was higher for delayed- versus early-onset HF ( P for heterogeneity =0.002). The age- and sex-adjusted 5-year survival estimates in 2001 to 2010 versus 1990 to 2000 were 82% and 81% among HF-free and 61% and 54% among HF patients, respectively ( P for heterogeneity of trends =0.05). Conclusions— HF markedly increases the risk of death after MI. This excess risk is similar regardless of ejection fraction but greater for delayed- versus early-onset HF. Mortality after MI declined over time, primarily as a result of improved HF survival.